SCHEMBL6697101

SCHEMBL6697101

O=C(O)COc1ccc(C=Cc2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.68
PPARA Q07869 3/20 0.66
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
PTPN7 P35236 2/20 0.61
FFAR1 O14842 2/20 0.61
RELA Q04206 1/20 0.59
ALDH1A1 P00352 2/20 0.59
MAPT P10636 1/20 0.59
PTPN12 Q05209 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.56
PPARG P37231 1/20 0.55
PPARD Q03181 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
THPO P40225 1/20 0.51
HIF1A Q16665 1/20 0.51
CHRNB4 P30926 1/20 0.51
CHRNA3 P32297 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6697095 1.00 ALOX15 (0.68) ALOX15PPARAMEN1KMT2APTPN7
SCHEMBL20024689 0.94 ALOX15 (0.63) ALOX15PPARAMEN1KMT2APTPN7
SCHEMBL20024742 0.87 ALOX15 (0.55) ALOX15PPARAMEN1KMT2APTPN7
SCHEMBL9786708 0.84 KEAP1 (0.52) ALOX15PPARAMEN1KMT2APTPN7
SCHEMBL20024695 0.84 ALOX15 (0.52) ALOX15PPARAMEN1KMT2APTPN7
Cinnamic Acid SCHEMBL27502592 0.84 ALOX15 (0.67) ALOX15PPARAMEN1KMT2APTPN7
SCHEMBL25212073 0.84 KMT2A (0.76) PPARAMEN1KMT2AALDH1A1MAPT
SCHEMBL25192238 0.84 KMT2A (0.76) PPARAMEN1KMT2AALDH1A1MAPT
SCHEMBL25199811 0.84 KMT2A (0.76) MEN1KMT2ARELAALDH1A1MAPT
SCHEMBL25190948 0.84 KMT2A (0.76) MEN1KMT2ARELAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235022-A1 Quality control method for manufacturing biopolymer arrays ROCHE DIAGNOSTICS GMBH (DE) 2004-11-25 US disclosed
EP-1466663-A1 Quality control method for manufacturing nucleic acid arrays F. HOFFMANN-LA ROCHE AG (CH) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235022-A1 Quality control method for manufacturing biopolymer arrays CTRL, PCBP1, PARG ALOX15 2928/4885PPARA 4657/4885MEN1 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.